comparemela.com

Latest Breaking News On - Tsx venture exchange rkv - Page 1 : comparemela.com

Rakovina Therapeutics Announces Results from 2023 Annual

VANCOUVER, British Columbia, June 28, 2023 (GLOBE NEWSWIRE) Rakovina Therapeutics Inc. (TSXV: RKV) (the “Company”), a biopharmaceutical company.

United kingdomBritish columbiaUnited statesDennis brownMichael liggettJeffrey bachaHealth canadaDrug administrationRakovina therapeutics incDavidson companyAlfredo de lucreziaUnited states foodTsx venture exchange rkvRakovina therapeutics inc

Rakovina Therapeutics Inc Announces Closing of $1 5

VANCOUVER, British Columbia, May 29, 2023 (GLOBE NEWSWIRE) Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) is pleased to.

United statesBritish columbiaUnited kingdomCompany the debenture unitsRakovina therapeutics incDrug administrationRegulation services providerCompany commonCompany theCompanya warrant shareVenture exchangeHealth canadaDebenture unitWarrant shareCommon sharesClosing date

Rakovina Therapeutics Inc Announces 2022 Financial Results

VANCOUVER, British Columbia, May 01, 2023 (GLOBE NEWSWIRE) Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”) a biopharmaceutical company.

Comunidad autonoma de catalunaUnited kingdomBritish columbiaUnited statesDavid hymanJeffrey bachaDrug administrationHealth canadaProactive investors nort america incRegulation services providerNational brain tumor societyAmerican association of cancer researchResearch developmentNational research council of canadaVenture exchangeRakovina therapeutics inc

Rakovina Therapeutics to Present at the Emerging Growth

VANCOUVER, British Columbia, April 17, 2023 (GLOBE NEWSWIRE) Rakovina Therapeutics Inc. (TSX-V: RKV) (“Rakovina” or the “Company”) is pleased to.

United statesBritish columbiaUnited kingdomAmerican association of cancer researchRegulation services providerRakovina therapeutics incDrug administrationHealth canadaEmerging growth conferenceAmerican associationCancer researchEmerging growthUnited states foodTsx venture exchange rkvRakovina therapeutics inc

Rakovina Therapeutics Inc Announces Q2 2022 Financial

VANCOUVER, British Columbia, Aug. 11, 2022 (GLOBE NEWSWIRE) Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”) a biopharmaceutical company.

United statesUnited kingdomBritish columbiaSummaryfinancial resultsforthequarterendedjuneJeffrey bachaToronto venture exchangeUniversity of british columbiaDrug administrationHealth canadaRakovina therapeutics incResearch developmentVincero capital corpRakovina therapeuticsFinancial resultsforthequarterendedjuneVincero capitalUnited states food

vimarsana © 2020. All Rights Reserved.